ICD-10 Code B60.0 | Babesiosis Symptoms, Diagnosis, Billing

Babesiosis is a malaria-like parasitic infection caused by protozoa of the genus Babesia, primarily transmitted through tick bites. It is clinically significant due to its potential to cause severe illness, particularly in immunocompromised individuals. Accurate coding with ICD-10 Code B60.0 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this infectious disease.

What is ICD-10 Code B60.0 for Babesiosis?

ICD-10 Code B60.0 represents Babesiosis, an infection caused by the Babesia parasite, often transmitted by Ixodes ticks. This code should be used in clinical documentation and billing when diagnosing patients with confirmed or suspected Babesiosis, particularly when presenting with symptoms such as fever, chills, and hemolytic anemia, to ensure appropriate treatment and reimbursement.

ICD-10 Code B60.0 – Clinical Definition and Explanation of Babesiosis

Babesiosis is caused by the protozoan parasites of the genus Babesia, which infect red blood cells and can lead to severe complications, especially in individuals with weakened immune systems. The condition requires prompt medical attention to prevent serious health outcomes.

Key Clinical Features:

• Fever and chills, often resembling malaria.
• Hemolytic anemia due to red blood cell destruction.
• Splenomegaly and hepatomegaly in severe cases.
• Potential for severe complications in immunocompromised patients.

ICD-10 Code B60.0 for Babesiosis – SOAP Notes & Clinical Use

ICD-10 Code B60.0 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to Babesiosis. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B60.0 for Babesiosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B60.0 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Babesiosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B60.0 – Babesiosis

Babesiosis may require hospitalization, especially in severe cases. Treatment typically involves specific antimicrobial therapy and supportive care.

Antibiotic Therapy:

• First-line: Atovaquone plus Azithromycin for 7-10 days.
• Alternative: Clindamycin plus Quinine for 7-10 days.
• Considerations for severe cases may include intravenous therapy.

Supportive Care:

• Fluid resuscitation to manage dehydration.
• Blood transfusions in cases of severe anemia.
• Monitoring for complications such as respiratory distress.

Infection Control:

• Implement standard precautions to prevent transmission.
• Educate patients on tick avoidance strategies.
• Monitor for outbreaks and report cases to public health authorities.

How to Document Symptoms of Babesiosis (ICD-10 B60.0) in SOAP Notes

Subjective:

• Patient reports fever, chills, and fatigue.
• History of tick exposure in endemic areas.
• Complaints of dark urine and jaundice.
• Recent travel to areas with known Babesiosis cases.

Objective:

• Vital signs: Elevated temperature (e.g., 102°F).
• Physical exam: Splenomegaly noted on palpation.
• Laboratory findings: Positive Babesia PCR test.
• Blood smear shows intraerythrocytic parasites.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Babesiosis (ICD-10 Code B60.0)

Assessment:

• Diagnosis: Babesiosis, moderate severity.
• ICD-10 Code: B60.0.
• Contributing factors: Recent tick exposure and immunocompromised status.

Plan:

• Initiate treatment with Atovaquone and Azithromycin.
• Educate patient on symptom monitoring and follow-up.
• Schedule follow-up appointment in one week.
• Consider referral to infectious disease specialist if no improvement.

Treatment & Plan Section for ICD-10 Code B60.0 – Babesiosis

• First-line pharmacologic treatment: Atovaquone plus Azithromycin.
• Non-pharmacologic strategies: Educate on tick prevention measures.
• Monitoring: Regular follow-up for symptom resolution and lab tests.
• Follow-up practices: Schedule re-evaluation in 1-2 weeks.

Using ICD-10 Code B60.0 for Babesiosis in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings.
• Document symptoms clearly under Subjective (S) and Objective (O) sections.
• Ensure treatment plans align with clinical guidelines for justified billing.
• Include relevant CPT codes for laboratory tests and consultations.

Related ICD-10 Codes Often Used with Babesiosis

• A92.0 – Dengue fever

ICD-10 Code B60.0 in Medical Billing and Insurance for Babesiosis

ICD-10 Code B60.0 is crucial for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis.
• Use the code in conjunction with appropriate CPT codes for services rendered.
• Ensure accurate coding to facilitate timely reimbursement.
• Review payer-specific guidelines for any additional documentation requirements.

Common CPT Pairings: